<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Cost Effectiveness and Resource Allocation via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Cost Effectiveness and Resource Allocation' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Cost+Effectiveness+and+Resource+Allocation&t=Cost+Effectiveness+and+Resource+Allocation&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 10:12:52 +0100</lastBuildDate>
        <item>
            <title>Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5654820&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F10%2F1%2F1</link>
            <description>Conclusions:
The review identified several model input data gaps, including utility values in partial responders, efficacy of second-line treatments, and resource utilisation estimates obtained from relevant, high-quality studies. It highlighted the differences in outcome measures among the trials of MDD interventions, which can lead to difficulty in performing indirect comparisons, and the inconsistencies in definitions of health states used in the clinical trials and those used in utility studies. Clinical outcomes contributed to the uncertainty in cost-effectiveness estimates to a greater degree than costs or utility weights. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654820</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5654820</guid>        </item>
        <item>
            <title>Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: A micro-costing study</title>
            <link>http://www.medworm.com/index.php?rid=5531393&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F18</link>
            <description>Conclusions:
For those receiving CM, the program adds 0.52% to the lifetime cost of ART. These data reflect wide variation in unit costs among the study sites and suggest that high patient volume may be a major determinant of CM program efficiency. The observed variations in unit costs also indicate that there may be opportunities to identify staffing patterns that increase overall program efficiency. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5531393</comments>
            <pubDate>Tue, 20 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5531393</guid>        </item>
        <item>
            <title>Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling</title>
            <link>http://www.medworm.com/index.php?rid=5427014&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F17</link>
            <description>Conclusions:
Lifestyle interventions for primary prevention of type 2 diabetes are cost-saving for men and women aged 30 or 50 years at the start of the intervention, and cost-effective for men and women aged 70 years. However, there is a high degree of uncertainty around the ICERs. With the conservative approach adopted for this model, the long-term effectiveness of the intervention could be underestimated. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5427014</comments>
            <pubDate>Fri, 18 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5427014</guid>        </item>
        <item>
            <title>Correction: The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions.</title>
            <link>http://www.medworm.com/index.php?rid=5353824&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F16</link>
            <description>After the publication of this article [Youngkong,Tromp, and Chitama; Cost Effectiveness and Resource Allocation, 2011. 9:8], we became aware that two last sentences in the paragraph relied on original ideas following personal communication with a researcher, and should not have been presented here. Consequently, the reference number 9 which was cited for the removed issue should be taken from the article. The correct paragraph is provided below: (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353824</comments>
            <pubDate>Wed, 26 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353824</guid>        </item>
        <item>
            <title>Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention</title>
            <link>http://www.medworm.com/index.php?rid=5499926&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F14</link>
            <description>Conclusions:
Major health gains can be realized efficiently by offering prevention to both the general and the diabetic population. However, a priori setting a specific distribution of resources is suboptimal. Resource allocation models allow accounting for capacity constraints and program size in addition to efficiency. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5499926</comments>
            <pubDate>Thu, 06 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5499926</guid>        </item>
        <item>
            <title>Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: 
a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5291520&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F15</link>
            <description>Conclusions:
The incremental cost-utility-ratios (ICER) show favourable values for GLA with considerable variation. If a willingness-to-pay threshold of GBP 30,000 (National Institute of Clinical Excellence, UK) is adopted, GLA is cost-effective in 4 of 6 cost utility analyses (CUA) included. Thus insulin glargine (GLA) seems to offer good value for money. Comparability between studies is limited because of methodological and country specific aspects. The results of this review underline that evaluation of insulin therapy should use evidence on efficacy of therapy from information synthesis. The concept of relating utility decrements to fear of hypoglycaemia is a plausible approach but needs further investigation. Also future evaluations of basal-bolus insulin therapy should include costs ...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5291520</comments>
            <pubDate>Thu, 06 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5291520</guid>        </item>
        <item>
            <title>Cost-Effectiveness of Continuous Glucose Monitoring and Intensive Insulin Therapy for Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5231425&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F13</link>
            <description>Conclusions:
CGM with intensive insulin therapy appears to be cost-effective relative to SMBG and other societal health interventions. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5231425</comments>
            <pubDate>Wed, 14 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5231425</guid>        </item>
        <item>
            <title>A systematic review of economic evaluations of health and health-related interventions in Bangladesh</title>
            <link>http://www.medworm.com/index.php?rid=5046648&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F12</link>
            <description>${item.shortDescription} (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5046648</comments>
            <pubDate>Tue, 19 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5046648</guid>        </item>
        <item>
            <title>Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda</title>
            <link>http://www.medworm.com/index.php?rid=4981287&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F11</link>
            <description>Conclusion:
Exclusive breastfeeding promotion in sub-Saharan Africa is feasible and can be implemented at a sustainable cost. The results of this study can be incorporated in cost effectiveness analyses of exclusive breastfeeding promotion programmes in sub-Saharan Africa. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4981287</comments>
            <pubDate>Tue, 28 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4981287</guid>        </item>
        <item>
            <title>Insomnia - treatment pathways, costs and quality of life</title>
            <link>http://www.medworm.com/index.php?rid=4958504&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F10</link>
            <description>Conclusions:
The study has brought to light a number of problems relating to the treatment of insomnia in New Zealand. There is both inadequate access to publicly funded treatment and insufficient publicly available information from which a consumer is able to make an informed decision on the treatment and provider options. This study suggests that successful treatment of insomnia leads to direct cost savings and improved quality of life. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4958504</comments>
            <pubDate>Mon, 20 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4958504</guid>        </item>
        <item>
            <title>Impact of the introduction of new vaccines and vaccine wastage rate on the cost-effectiveness of routine EPI: lessons from a descriptive study in a Cameroonian health district</title>
            <link>http://www.medworm.com/index.php?rid=4875962&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F9</link>
            <description>The Expanded Program of Immunization (EPI) offers services to the population free of charge but these activities are costly with the greatest part being the cost of vaccines. In spite of the growing international solidarity towards funding for immunization, the growing objectives continue to outweigh the available resources. It is therefore crucial for any immunization system to seek greater efficiency so as to optimize the use of available means in a bid to ensure sustainability. It is in this light that we carried out this study which aims to assess the productive efficiency of routine EPI for children aged 0 - 11 months with respect to the fixed and outreach vaccine delivery strategies in Ngong health district. The study is descriptive and cross-sectional. Data were collected retrospect...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4875962</comments>
            <pubDate>Fri, 27 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4875962</guid>        </item>
        <item>
            <title>The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions.</title>
            <link>http://www.medworm.com/index.php?rid=4838227&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F8</link>
            <description>This commentary responds to the article by Goetghebeur et al., which applies the EVIDEM (Evidence and Value: Impact on DEcision-Making) framework to evaluate growth hormone therapy for Turner syndrome patients. While we value the qualities of the EVIDEM because of its scope and breadth, we have doubts on the results consistency of the EVIDEM to compare competing interventions, particularly when setting priorities across broad healthcare service areas (e.g. in designing the national health benefit package) for two main reasons. First, the EVIDEM framework ignores the contextual nature of priority setting process by assuming a set of universal priority setting criteria. Secondly, the EVIDEM is vulnerable to interventions ranking inconsistency where performance evaluation of a broad range of ...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4838227</comments>
            <pubDate>Wed, 18 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4838227</guid>        </item>
        <item>
            <title>multidimensional evaluation of performance with experimental application of balanced scorecard: a two year experience.</title>
            <link>http://www.medworm.com/index.php?rid=4838228&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F7</link>
            <description>Conclusions:
The first use of BSC to compare performance at Operative Unit level, in course of time, suggested this framework can be successfully adopted for results measuring and revealing effective health factors, allowing health-care quality improvements. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4838228</comments>
            <pubDate>Mon, 16 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4838228</guid>        </item>
        <item>
            <title>Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=4818716&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F6</link>
            <description>Conclusions:
There are good economic arguments to recommend generic risperidone as first line treatment in combination with family intervention. As the uncertainty interval indicates the addition of clozapine may be dominated and there are serious side effects, treating severe patients with clozapine is advisable only for patients who do not respond to risperidone and only in the presence of a stricter side effect monitoring system than currently exists. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4818716</comments>
            <pubDate>Thu, 12 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4818716</guid>        </item>
        <item>
            <title>Economic Modeling of the Combined Effects of HIV-Disease,
Cholesterol and Lipoatrophy Based on ACTG 5142 Trial Data</title>
            <link>http://www.medworm.com/index.php?rid=4801152&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F5</link>
            <description>Conclusion:
The cost effectiveness of ARV regimens may be strongly affected by enduring AEs, such as lipoatrophy.. It is important to consider specific AE effects from all drug in a regimen when ARVs are compared. (ClinicalTrials.gov number, NCT00050895 [ClinicalTrials.gov]). (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4801152</comments>
            <pubDate>Sat, 07 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4801152</guid>        </item>
        <item>
            <title>The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic review</title>
            <link>http://www.medworm.com/index.php?rid=4454290&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F3</link>
            <description>Conclusions and RecommendationsInterventions to prevent HIV MTCT are compelling on economic grounds in many resource-limited settings and should remain at the forefront of global HIV prevention efforts. Future cost-effectiveness analyses can help to ensure that pMTCT interventions for LMICs reach their full potential by focussing on unanswered questions in four areas: local assessment of rapidly evolving HIV MTCT options; strategies to improve coverage and reach underserved populations; evaluation of a more comprehensive set of MTCT approaches including primary HIV prevention and reproductive counselling; integration of HIV MTCT and other sexual and reproductive health services. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4454290</comments>
            <pubDate>Wed, 09 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4454290</guid>        </item>
        <item>
            <title>Cost-effectiveness of three malaria treatment strategies in rural Tigray, Ethiopia where both Plasmodium falciparum and Plasmodium vivax co-dominate</title>
            <link>http://www.medworm.com/index.php?rid=4449268&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F2</link>
            <description>Conclusion:
This study showed that the parascreen pan/pf based strategy should be the preferred option to be used at health post level in rural Tigray. This finding is relevant nationwide as the entire country's malaria epidemiology is similar to the study area. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4449268</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4449268</guid>        </item>
        <item>
            <title>The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs</title>
            <link>http://www.medworm.com/index.php?rid=4381451&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F9%2F1%2F1</link>
            <description>Conclusions:
Study results indicate that chronic fatigue syndrome may lead to substantial increases in healthcare costs and decreases in individual earnings. Studies have estimated up to 2.5% of non-elderly adults may suffer from CFS. In Georgia, a state with roughly 5.5 million people age 18-59, illness could account for $452 million in total healthcare expenditures and $1.2 billion of lost productivity. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4381451</comments>
            <pubDate>Fri, 21 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4381451</guid>        </item>
        <item>
            <title>Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach</title>
            <link>http://www.medworm.com/index.php?rid=4174427&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F21</link>
            <description>Conclusions:
Our analysis shows the potential for large health benefits and cost savings of stroke services, taking a lifetime perspective, also in other European settings. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4174427</comments>
            <pubDate>Wed, 17 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4174427</guid>        </item>
        <item>
            <title>Can choices between alternative hip prostheses be evidence based? A review of the economic evaluation literature</title>
            <link>http://www.medworm.com/index.php?rid=4115398&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F20</link>
            <description>Conclusions:
More clinical trials including long term follow-up and economic evaluation are needed. These should compare the cost-effectiveness of different prostheses with longer-term follow-up and including a wider perspective. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4115398</comments>
            <pubDate>Thu, 28 Oct 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4115398</guid>        </item>
        <item>
            <title>To what extent does recurrent government health expenditure in Uganda reflect its policy priorities?</title>
            <link>http://www.medworm.com/index.php?rid=4094531&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F19</link>
            <description>Conclusion:
The policy aspiration of increasing spending on PHC was attained but key aspects that would facilitate its realization were not addressed. At any given level of funding for the health sector, there is need to work out an optimal balance in investment in the different inputs to ensure efficiency in health spending. Equally important is the balance in investment between hospitals and health centers. There is a need to look comprehensively at what it takes to provide PHC services and invest accordingly. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4094531</comments>
            <pubDate>Tue, 19 Oct 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4094531</guid>        </item>
        <item>
            <title>Cost-effectiveness of injury prevention - a systematic review of municipality based interventions</title>
            <link>http://www.medworm.com/index.php?rid=3956884&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F17</link>
            <description>Conclusions:
The results indicate that there are injury prevention interventions that offer good use of societal resources. However, there is a lack of economic evidence surrounding injury prevention interventions. This lack of evidence needs to be met by further research about the economic aspects of injury prevention interventions to improve the information available for decision-making. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3956884</comments>
            <pubDate>Thu, 09 Sep 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3956884</guid>        </item>
        <item>
            <title>The scope of costs in alcohol studies: Cost-of-illness studies differ from economic evaluations</title>
            <link>http://www.medworm.com/index.php?rid=3726119&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F15</link>
            <description>Conclusions:
The costs included in economic evaluations performed from a societal perspective do not correspond with those included in cost-of-illness studies. Economic evaluations on alcohol abuse underreport true societal cost of alcohol abuse. When considering implementation of alcohol abuse interventions, policy makers should take into account that economic evaluations from the societal perspective might underestimate the total effects and costs of interventions. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3726119</comments>
            <pubDate>Mon, 05 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3726119</guid>        </item>
        <item>
            <title>Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada</title>
            <link>http://www.medworm.com/index.php?rid=3670197&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F14</link>
            <description>Conclusions:
Based on common willingness to pay thresholds, IVIG would not be perceived as a cost effective treatment for CIDP. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3670197</comments>
            <pubDate>Wed, 16 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3670197</guid>        </item>
        <item>
            <title>Cost-effectiveness analysis of clinical specialist outreach as compared to referral system in Ethiopia: an economic evaluation</title>
            <link>http://www.medworm.com/index.php?rid=3654981&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F13</link>
            <description>Conclusion:
Clinical specialist outreach is a cost effective and cost saving way of spending clinical specialists' time as compared to provision of similar services through referral system. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3654981</comments>
            <pubDate>Thu, 10 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3654981</guid>        </item>
        <item>
            <title>Cost recovery of NGO primary health care facilities: a case study in Bangladesh</title>
            <link>http://www.medworm.com/index.php?rid=3643737&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F12</link>
            <description>Conclusion:
The cost recovery of this NGO primary care facility is important for increasing its financial sustainability and decreasing donor dependency, and achieving universal health coverage in a developing country setting. However, for improving the cost recovery of the health facility, it needs to increase utilization, efficient planning, resource allocation and their optimum use. It also requires controlling variable costs and preventing any wastage of resources. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3643737</comments>
            <pubDate>Tue, 08 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3643737</guid>        </item>
        <item>
            <title>Cost-effectiveness of a pressure ulcer quality collaborative</title>
            <link>http://www.medworm.com/index.php?rid=3617205&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F11</link>
            <description>Conclusions:
During the QIC PU incidence and prevalence significantly declined. When compared to standard PU care, the QIC was probably more costly and more effective in the short run, but its long-term cost-effectiveness is questionable. The QIC can only be cost-effective if the changes in incidence and prevalence of PU are sustained. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3617205</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3617205</guid>        </item>
        <item>
            <title>Cost-effectiveness implications of GP intervention to promote physical activity: evidence from Perth, Australia</title>
            <link>http://www.medworm.com/index.php?rid=3559142&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F10</link>
            <description>Conclusion:
Implementing a subsidy for GP advice could potentially reduce the burden of physical inactivity. However, the cost-effectiveness of a subsidy program for GP advice depends on the percentage of population who comply with GP advice. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3559142</comments>
            <pubDate>Wed, 12 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3559142</guid>        </item>
        <item>
            <title>Measuring the time costs of exercise: a proposed measuring method and a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=3551349&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F9</link>
            <description>Background:
The cost of time spent on exercise is an important factor in societal-perspective health economic analyses of interventions aimed at promoting physical activity. However, there are no existing measuring methods for estimating time costs. The aim of this article is to describe a way to measure the costs of time spent on physical activity. We propose a model for measuring these time costs, and present the results of a pilot study applying this model to different groups of exercisers.
Methods:
We began this investigation by developing a model for measuring the time spent on exercise, based on the most important theoretical frameworks for valuing time. In the model, the value of utility in anticipation (expected health benefits) of performing exercise is expressed in terms of healt...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3551349</comments>
            <pubDate>Mon, 10 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3551349</guid>        </item>
        <item>
            <title>Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy</title>
            <link>http://www.medworm.com/index.php?rid=3551350&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F8</link>
            <description>Objectives:The aim was to evaluate direct health care costs of central line-associated bloodstream infections (CLABSI) and to calculate the cost-effectiveness ratio of closed fully collapsible plastic intravenous infusion containers vs. open (glass) infusion containers.
Methods:
A two-year, prospective case-control study was undertaken in four intensive care units in an Italian teaching hospital. Patients with CLABSI (cases) and patients without CLABSI (controls) were matched for admission departments, gender, age, and average severity of illness score. Costs were estimated according to micro-costing approach. In the cost effectiveness analysis, the cost component was assessed as the difference between production costs while effectiveness was measured by CLABSI rate (number of CLABSI per 1...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3551350</comments>
            <pubDate>Sun, 09 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3551350</guid>        </item>
        <item>
            <title>A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK</title>
            <link>http://www.medworm.com/index.php?rid=3518275&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F7</link>
            <description>Conclusions:
Using the commonly accepted threshold of GBP30,000 per QALY gained in the UK, most scenarios of vaccination programmes preventing HZ and PHN, including the potential use of a repeat dose, may be considered cost-effective by the NHS, especially within the 60 to 69 age-groups. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3518275</comments>
            <pubDate>Thu, 29 Apr 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3518275</guid>        </item>
        <item>
            <title>Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom</title>
            <link>http://www.medworm.com/index.php?rid=3507165&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F6</link>
            <description>Conclusion:
The economic and disease burden of aSAH in the United Kingdom is reported in this study. Decision-makers can use these results to complement other information when informing prevention policies in this field and to relate health care expenditures to disease categories. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3507165</comments>
            <pubDate>Mon, 26 Apr 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3507165</guid>        </item>
        <item>
            <title>Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients</title>
            <link>http://www.medworm.com/index.php?rid=3447699&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F4</link>
            <description>Conclusions:
This framework is proposed as a pragmatic step beyond the current cost-effectiveness model, combining HTA, MCDA, values and ethics. It supports systematic consideration of all components of decision and available evidence for greater transparency. Further testing and validation is needed to build up MCDA approaches combined with pragmatic HTA in healthcare decisionmaking. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3447699</comments>
            <pubDate>Wed, 07 Apr 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3447699</guid>        </item>
        <item>
            <title>Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis</title>
            <link>http://www.medworm.com/index.php?rid=3377352&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F2</link>
            <description>Conclusions:
From a cost-effectiveness standpoint, screening programmes should be expanded in developed regions and treatment programmes should be established for colorectal cancer in regions with low treatment coverage. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3377352</comments>
            <pubDate>Wed, 17 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3377352</guid>        </item>
        <item>
            <title>Giving tranexamic acid to reduce surgical bleeding in Sub-Saharan Africa: an economic evaluation</title>
            <link>http://www.medworm.com/index.php?rid=3282724&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F8%2F1%2F1</link>
            <description>Conclusion:
An economic argument can be made for giving TXA to bleeding elective surgical patients. In countries where there is a blood shortage, TXA would be a cost effective way to reduce mortality. In countries where there is no blood shortage, TXA would reduce healthcare costs and avert blood borne infections. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3282724</comments>
            <pubDate>Wed, 17 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3282724</guid>        </item>
        <item>
            <title>Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis</title>
            <link>http://www.medworm.com/index.php?rid=3081681&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F20</link>
            <description>Conclusions:
The ICURs of anti-TNF-alpha drugs were not satisfactory in treating patients with moderate-to-severe refractory UC. Future research could be aimed at the long-term clinical benefits of these drugs, especially adalimumab for patients intolerance or failed infliximab treatment. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3081681</comments>
            <pubDate>Fri, 11 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3081681</guid>        </item>
        <item>
            <title>The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan</title>
            <link>http://www.medworm.com/index.php?rid=2953624&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F19</link>
            <description>Conclusion:
While the cost-effectiveness of similar programmes have been previously assessed using modelled data, more work needs to be done to assess the costs of new programmes in relation to financial resources available. Full costing should consider cost-savings as well as expenditures. If feasible, the impact of the programme should be monitored over time. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2953624</comments>
            <pubDate>Tue, 03 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2953624</guid>        </item>
        <item>
            <title>Can economic evaluation of telemedicine be trusted? A systematic review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=2922639&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F18</link>
            <description>Conclusion:
As this paper demonstrates, the majority of the economic evaluations reviewed were not in accordance with standard evaluation techniques. Further research is needed to explore the reasons for this and to address how economic evaluation in telemedicine best can take advantage of local constraints and at the same time produce valid and generalisable results. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2922639</comments>
            <pubDate>Fri, 23 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2922639</guid>        </item>
        <item>
            <title>Medical net cost of low alcohol consumption - a cause to reconsider improved health as the link between alcohol and wage?</title>
            <link>http://www.medworm.com/index.php?rid=2919013&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F17</link>
            <description>Conclusion:
Using health as an explanation in the alcohol-wage literature appears invalid when applying the full epidemiological information instead of selected information. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2919013</comments>
            <pubDate>Thu, 22 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2919013</guid>        </item>
        <item>
            <title>Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia</title>
            <link>http://www.medworm.com/index.php?rid=2915202&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F16</link>
            <description>Conclusion:
In the face of insufficient data, a cost analysis exercise is a difficult but feasible undertaking. The study findings are useful and applicable in similar settings, and can be used in cost effectiveness analyses of health interventions. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2915202</comments>
            <pubDate>Tue, 20 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2915202</guid>        </item>
        <item>
            <title>Cost-Effectiveness and Resource Allocation (CERA) - directions for the future</title>
            <link>http://www.medworm.com/index.php?rid=2633292&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F14</link>
            <description>The journal Cost-Effectiveness and Resource Allocation (CERA) is now in its seventh year, and is an excellent example of how open access publishing can improve dissemination. Now the journal is through its infancy, it is time to reflect on its orientation and to define the strategy for the years to come. Firstly, the journal will pay particular attention to stimulating and publishing studies originating from low- and middle-income countries. Second, CERA will continue to solicit contributions originating from high-income countries, but with the caveat that such studies should be of interest to the broad international readership of the journal. Third, the journal encourages submissions on methodological work from any setting, that is generalisable between low-, middle-, and high income coun...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2633292</comments>
            <pubDate>Wed, 22 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2633292</guid>        </item>
        <item>
            <title>Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain</title>
            <link>http://www.medworm.com/index.php?rid=2613081&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F12</link>
            <description>Background:
Different utility measures can be used within cost-effectiveness analyses, where these may provide different results. We sought to compare the practicality, validity and responsiveness of using each of two utility measures (the EQ-5D and SF-6D) to measure the benefits of alleviating knee pain.
Methods:
Participants in a randomised controlled trial, which was designed to compare four different interventions for people with self-reported knee pain, were asked to complete the EQ-5D, SF-6D, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at both pre- and post-intervention. For both utility measures, we assessed their practicality (completion rate), construct validity (ability to discriminate between baseline WOMAC severity levels), and responsiveness (abi...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2613081</comments>
            <pubDate>Thu, 16 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2613081</guid>        </item>
        <item>
            <title>Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia</title>
            <link>http://www.medworm.com/index.php?rid=2613080&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F13</link>
            <description>Conclusion:
The undiscounted and discounted incremental costs per LYG from introducing ART were less than the per capita GDP threshold at the base year. Thus, ART could be regarded as cost-effective in a district hospital setting in Ethiopia. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2613080</comments>
            <pubDate>Thu, 16 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2613080</guid>        </item>
        <item>
            <title>Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina</title>
            <link>http://www.medworm.com/index.php?rid=2395832&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F10</link>
            <description>Conclusions:
Against a threshold of average per capita income in Argentina, the two selected population-based interventions (lowering salt intake and health education through mass-media campaigns) plus the modified polypill strategy targeting people with a 20% or greater risk were cost-effective. Use of this methodology in developing countries can make resource-allocation decisions less intuitive and more driven by evidence. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2395832</comments>
            <pubDate>Wed, 06 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2395832</guid>        </item>
        <item>
            <title>Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective</title>
            <link>http://www.medworm.com/index.php?rid=2395833&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F9</link>
            <description>Conclusions:
The findings of this modelling analysis indicated that, for patients with a history of macrovascular disease, addition of pioglitazone to existing therapy reduces the long-term cumulative incidence of diabetes-complications at a cost that would be considered to represent good value for money in the German setting. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2395833</comments>
            <pubDate>Tue, 05 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2395833</guid>        </item>
        <item>
            <title>Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial</title>
            <link>http://www.medworm.com/index.php?rid=2363135&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F8</link>
            <description>Conclusion:
This is the first economic evaluation alongside a prevention trial in panic disorder. The small sample (n=117) and the short time horizon of 3 months preclude firm conclusions, but our findings suggest that the intervention may be acceptable from a cost-effectiveness point of view, especially when therapist involvement can be kept minimal. Nevertheless, our results must await replication in a larger trial with longer follow-up times before we can confidently recommend implementation of the intervention on a broad scale. In the light of our findings and given the burden of panic disorder, such a new trial is well worth the effort. 
Trial registration: Current Controlled Trials ISRCTN33407455. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2363135</comments>
            <pubDate>Fri, 24 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2363135</guid>        </item>
        <item>
            <title>Single food focus dietary guidance: lessons learned from an economic analysis of egg consumption</title>
            <link>http://www.medworm.com/index.php?rid=2338547&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F7</link>
            <description>Conclusions:
This study evaluating the economic impact of egg consumption suggests that public health campaigns promoting limiting egg consumption as a means to reduce CHD risk would not be cost-effective from a societal perspective when other benefits are considered. Public health intervention that focuses on a single dietary constituent, and foods that are high in that constituent, may lead to unintended consequences of removing other beneficial constituents and the net effect may not be in its totality a desirable public health outcome. As newer data become available, the model should be updated. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2338547</comments>
            <pubDate>Tue, 14 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2338547</guid>        </item>
        <item>
            <title>Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia</title>
            <link>http://www.medworm.com/index.php?rid=2338548&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F6</link>
            <description>Conclusion:
The cost profile of ART at a district hospital level may be useful in the planning and budgeting of implementing ART programs in Ethiopia. Further studies that focus on patient costs are warranted to capture all patterns of service use and relevant costs. Economic evaluations combining cost estimates with clinical outcomes would be useful for ranking of ART services. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2338548</comments>
            <pubDate>Mon, 13 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2338548</guid>        </item>
        <item>
            <title>Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States</title>
            <link>http://www.medworm.com/index.php?rid=2321160&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F4</link>
            <description>Conclusions:
The utilization of olanzapine is predicted in this model to result in better clinical outcomes and lower total direct health care costs compared to generic risperidone, quetiapine, ziprasidone, and aripiprazole. Olanzapine may, therefore, be a cost-effective therapeutic option for patients with schizophrenia. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2321160</comments>
            <pubDate>Tue, 07 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2321160</guid>        </item>
        <item>
            <title>The economic burden of inpatient paediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis</title>
            <link>http://www.medworm.com/index.php?rid=2179732&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F3</link>
            <description>Conclusion:
Treatments cost for inpatient malaria, pneumonia and meningitis vary by facility type, with mission and tertiary referral facilities being more expensive compared to primary referral. Households of sick children contribute significantly towards provider cost through payment of user fees. These findings could be used in cost effectiveness analysis of health interventions. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2179732</comments>
            <pubDate>Thu, 22 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2179732</guid>        </item>
        <item>
            <title>The economic burden of inpatient paediatric care: household and provider costs for treatment of pneumonia, malaria and meningitis</title>
            <link>http://www.medworm.com/index.php?rid=2123762&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F3</link>
            <description>Conclusions:
Treatments cost for inpatient malaria, pneumonia and meningitis vary by facility type, with mission and tertiary referral facilities being more expensive compared to primary referral. Households of sick children contribute significantly towards provider cost through payment of user fees. These findings could be used in cost effectiveness analysis of health interventions. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2123762</comments>
            <pubDate>Thu, 22 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2123762</guid>        </item>
        <item>
            <title>Cost effectiveness of community-based therapeutic care for children with severe acute malnutrition in Zambia: decision tree model</title>
            <link>http://www.medworm.com/index.php?rid=2106154&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F2</link>
            <description>Conclusions:
CTC is relatively cost effective compared to other priority health care interventions in developing countries, for a wide range of assumptions. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2106154</comments>
            <pubDate>Thu, 15 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2106154</guid>        </item>
        <item>
            <title>Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali</title>
            <link>http://www.medworm.com/index.php?rid=2088543&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F7%2F1%2F1</link>
            <description>Conclusion:
This study demonstrates that the IDSR strategy can be considered a low cost public health system although the benefits have yet to be quantified. These data can also be used in future studies of the cost-effectiveness of IDSR. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2088543</comments>
            <pubDate>Thu, 08 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2088543</guid>        </item>
        <item>
            <title>Capacity utilization and the cost of primary care visits: Implications for the costs of scaling up health interventions</title>
            <link>http://www.medworm.com/index.php?rid=1957624&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F22</link>
            <description>ObjectiveA great deal of international attention has been focussed recently on how much additional funding is required to scale up health interventions to meet global targets such as the Millennium Development Goals (MDGs). Most of the cost estimates that have been made in response have assumed that unit costs of delivering services will not change as coverage increases or as more and more interventions are delivered together. This is most unlikely. The main objective of this paper is to measure the impact of patient load on the cost per visit at primary health care facilities and the extent to which this would influence estimates of the costs and financial requirements to scale up interventions. 
Methods:
Multivariate regression analysis was used to explore the determinants of variability...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1957624</comments>
            <pubDate>Thu, 13 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1957624</guid>        </item>
        <item>
            <title>Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors</title>
            <link>http://www.medworm.com/index.php?rid=1954015&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F21</link>
            <description>Conclusions:
From a Mexican institutional perspective and probably in other Social Security Institutions in similar developing countries, the most cost-effective option for treatment of knee and/or hip OA would be celecoxib. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1954015</comments>
            <pubDate>Wed, 12 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1954015</guid>        </item>
        <item>
            <title>Societal costs of air pollution-related health hazards: A review of methods and results</title>
            <link>http://www.medworm.com/index.php?rid=1784941&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F19</link>
            <description>This paper aims to provide a critical and systematic review of the societal costs of air pollution-related ill health (CAP), to explore methodological issues that may be important when assessing or comparing CAP across countries and to suggest ways in which future CAP studies can be made more useful for policy analysis. The methodology includes a systematic search based on the major electronic databases and the websites of a number of major international organizations. Studies are categorized by origin -- OECD countries or non-OECD countries -- and by publication status. Seventeen studies are included, eight from OECD countries and nine from non-OECD countries. A number of studies based on the ExternE methodology and the USA studies conducted by the Institute of Transportation are also sum...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1784941</comments>
            <pubDate>Thu, 11 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1784941</guid>        </item>
        <item>
            <title>Cost-effectiveness of smoking cessation to prevent age-related macular degeneration</title>
            <link>http://www.medworm.com/index.php?rid=1781271&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F18</link>
            <description>Conclusions:
Smoking cessation is unequivocally cost-effective in terms of its impact on age-related macular degeneration outcomes alone. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1781271</comments>
            <pubDate>Thu, 11 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1781271</guid>        </item>
        <item>
            <title>The costs of traumatic brain injury due to motorcycle accidents in Hanoi, Vietnam</title>
            <link>http://www.medworm.com/index.php?rid=1721960&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F17</link>
            <description>Conclusions:
All three component costs of TBI were high; the direct cost accounted for the largest proportion, with costs rising with the severity of TBI. The results suggest that the burden of TBI can be catastrophic for families because of high direct costs, significant time off work for patients and caregivers, and impact on health-related quality of life. Further research is warranted to explore the actual social and economic benefits of mandatory helmet use. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1721960</comments>
            <pubDate>Fri, 22 Aug 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1721960</guid>        </item>
        <item>
            <title>People's willingness to pay for health insurance in rural Vietnam</title>
            <link>http://www.medworm.com/index.php?rid=1698626&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F16</link>
            <description>Conclusions:
Since WTP is sufficient to cover household costs for public health care, it depends to what extent households would substitute private for public care and increase utilization as to whether WTP would also be sufficient enough to finance health insurance. This study highlights potential for public information schemes that may change the negative attitude towards health insurance, which this study has uncovered. A key task for policy makers is to win the trust of the population in relation to a health insurance system, particularly among the old and those with relatively low education. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1698626</comments>
            <pubDate>Mon, 11 Aug 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1698626</guid>        </item>
        <item>
            <title>Setting priorities for the health care sector in Zimbabwe using cost-effectiveness analysis and estimates of the burden of disease</title>
            <link>http://www.medworm.com/index.php?rid=1659109&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F14</link>
            <description>Conclusions:
The present study showed that it was feasible to conduct cost-effectiveness analyses for a large number of health interventions in a developing country like Zimbabwe using a consistent methodology. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1659109</comments>
            <pubDate>Mon, 28 Jul 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1659109</guid>        </item>
        <item>
            <title>Decision-maker views on priority setting in the Vancouver Island Health Authority</title>
            <link>http://www.medworm.com/index.php?rid=1641160&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F13</link>
            <description>Conclusions:
This study makes a contribution to a growing body of knowledge which provides the type of contextual evidence that is required if priority setting processes are to be used successfully by health care decision-makers. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1641160</comments>
            <pubDate>Mon, 21 Jul 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1641160</guid>        </item>
        <item>
            <title>Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration</title>
            <link>http://www.medworm.com/index.php?rid=1539896&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F12</link>
            <description>Conclusions:
From a societal perspective, ranibizumab was cost-saving. From a health care funder's perspective, ranibizumab was an efficient treatment when it cost less than $1000 per dose. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1539896</comments>
            <pubDate>Tue, 24 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1539896</guid>        </item>
        <item>
            <title>Non-pharmaceutical prevention of hip fractures - a cost-effectiveness analysis of a community-based elderly safety promotion program in Sweden</title>
            <link>http://www.medworm.com/index.php?rid=1478927&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F11</link>
            <description>Conclusions:
The community-based elderly safety promotion program aiming at preventing accidental falls seems as cost-effective as osteoporosis pharmaceuticals. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1478927</comments>
            <pubDate>Fri, 30 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1478927</guid>        </item>
        <item>
            <title>Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States</title>
            <link>http://www.medworm.com/index.php?rid=1464858&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F10</link>
            <description>Conclusions:
The formulas developed in this study can be a useful tool for STI program personnel to generate evidence-based estimates of the economic impact of their program and can facilitate the assessment of the cost-effectiveness of their activities. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1464858</comments>
            <pubDate>Fri, 23 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1464858</guid>        </item>
        <item>
            <title>Is the value of a life or life-year saved context specific? Further evidence from a discrete choice experiment</title>
            <link>http://www.medworm.com/index.php?rid=1452594&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F8</link>
            <description>Conclusions:
Results confirm that a trade-off exists between cost, effectiveness and non-health arguments when respondents prioritise health programs. That said, it is true that respondents were more likely to select less costly, more effective interventions - confirming that it is an adjustment to, rather than an outright rejection of, simple health maximisation that is required. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1452594</comments>
            <pubDate>Tue, 20 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1452594</guid>        </item>
        <item>
            <title>Review of Australian health economic evaluation- 245 interventions: what can we say about cost-effectiveness?</title>
            <link>http://www.medworm.com/index.php?rid=1452593&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F9</link>
            <description>Background:
There is an increasing body of published cost-utility analyses of health interventions which we sought to draw together to inform research and policy. Methods: To achieve consistency in costing base and policy context, study scope was limited to Australian-based cost-effectiveness analyses. Through a comprehensive literature review we identified 245 health care interventions that met our study criteria. Results: The median cost-effectiveness ratio was A$18,100 (~US$13,000) per QALY/DALY/LY (quality adjusted life year gained or, disability adjusted life year averted or life year gained). Some modalities tended to perform worse, such as vaccinations and diagnostics (median cost/QALY $58,000 and $68,000 respectively), than others such as allied health, lifestyle, in-patient interv...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1452593</comments>
            <pubDate>Tue, 20 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1452593</guid>        </item>
        <item>
            <title>S4HARA: System for HIV/AIDS resource allocation</title>
            <link>http://www.medworm.com/index.php?rid=1329533&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F7</link>
            <description>Conclusions:
Condom uptake at the clinic should be increased by changing the condom distribution policy from a pull system to a push system. NGOs and donors promoting antiretroviral programs at the clinic should be sensitized to the results of the model and urged to invest in wellness programs aimed at the prevention and treatment of opportunistic infections. S4HARA differentiates itself from other decision support tools by providing rational HIV/AIDS resource allocation capabilities as well as consideration of the realities facing authorities in their decision-making process. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1329533</comments>
            <pubDate>Wed, 26 Mar 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1329533</guid>        </item>
        <item>
            <title>Does productivity influence priority setting? A case study from the field of CVD prevention</title>
            <link>http://www.medworm.com/index.php?rid=1306940&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F6</link>
            <description>In this case study, different measures aimed at preventing cardiovascular diseases (CVD) in different target groups have been ranked based on cost per QALY from a health care sector perspective and from a societal perspective, respectively. The innovation in this study is to introduce a budget constraint and thereby show exactly which groups would be included or excluded in treatment or intervention programs based on the two perspectives. Approximately 90% of the groups are included in both perspectives. Mainly elderly women are excluded when the societal perspective is used and mainly middle-aged men are excluded when the health care sector perspective is used. Elderly women have a higher risk of CVD and generally lower income than middle-aged men. Thus the exclusion of older women in the...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1306940</comments>
            <pubDate>Mon, 17 Mar 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1306940</guid>        </item>
        <item>
            <title>Could CT screening for lung cancer ever be cost effective in the United Kingdom ?</title>
            <link>http://www.medworm.com/index.php?rid=1256693&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F5</link>
            <description>Conclusion:
It is evident that eventually being able to identify a cost effective regimen of CT screening for lung cancer in the UK is by no means an unreasonable expectation. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1256693</comments>
            <pubDate>Tue, 26 Feb 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1256693</guid>        </item>
        <item>
            <title>Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis</title>
            <link>http://www.medworm.com/index.php?rid=1233689&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F4</link>
            <description>Conclusions:
These analyses suggest that adding a quadrivalent HPV vaccine to current screening in the UK could be a cost-effective method for further reducing the burden of cervical cancer. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1233689</comments>
            <pubDate>Fri, 15 Feb 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1233689</guid>        </item>
        <item>
            <title>The cost of antiretroviral therapy in Haiti</title>
            <link>http://www.medworm.com/index.php?rid=1232525&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F3</link>
            <description>Conclusion:
Initial ART treatment in Haiti costs approximately $US 1,000 per patient per year. With generic first-line antiretroviral drugs, only 36% of the cost is for medications. Patients who change regimens are significantly more expensive to treat, highlighting the need for less-expensive second-line drugs. There may be sufficient health care personnel to treat all HIV-infected patients in urban areas of Haiti, but not in rural areas. New models of HIV care are needed for rural areas using assistant medical officers and community health workers. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1232525</comments>
            <pubDate>Thu, 14 Feb 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1232525</guid>        </item>
        <item>
            <title>Integrating tuberculosis and HIV services for people living with HIV: costs of the Zambian ProTEST Initiative</title>
            <link>http://www.medworm.com/index.php?rid=1171486&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F2</link>
            <description>Conclusions:
This study shows that coordinating an integrated and comprehensive package of services for PLWH is relatively inexpensive. The lessons learnt in this study are still applicable today in the era of ART, as these services must still be provided as part of the continuum of care for people living with HIV. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1171486</comments>
            <pubDate>Wed, 23 Jan 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1171486</guid>        </item>
        <item>
            <title>Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: the role of time since cessation</title>
            <link>http://www.medworm.com/index.php?rid=1147187&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F6%2F1%2F1</link>
            <description>Conclusions:
The results show that simulation models are sensitive to assumptions made in specifying the model. The model should be specified carefully in accordance with the questions it is supposed to answer. If the aim of the model is to estimate effects of smoking cessation interventions on mortality and morbidity, one should include relapse of quitters and dependency on time since cessation of incidence rates of smoking-related chronic diseases. A drawback of such models is that data requirements are extensive. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1147187</comments>
            <pubDate>Fri, 11 Jan 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1147187</guid>        </item>
        <item>
            <title>Cost-utility analysis of a national project to reduce hypertension in Israel</title>
            <link>http://www.medworm.com/index.php?rid=1056139&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F16</link>
            <description>Conclusions:
The project which saves both lives and resources should be extended nation-wide to reach as wide a population as possible. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1056139</comments>
            <pubDate>Wed, 28 Nov 2007 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1056139</guid>        </item>
        <item>
            <title>Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands</title>
            <link>http://www.medworm.com/index.php?rid=1044601&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F15</link>
            <description>Conclusion:
We estimated the iCER for TPV/r compared to CPI/r at approximately E40,000 in treatment experienced HIV-1 infected patients in the Netherlands. This ratio may well be in range of what is acceptable and warrants reimbursement for new drug treatments in the Netherlands, in particular in therapeutic areas as end-stage oncology and HIV and other last-resort health-care interventions. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1044601</comments>
            <pubDate>Thu, 22 Nov 2007 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1044601</guid>        </item>
        <item>
            <title>The effect of environmental factors on technical and scale efficiency of primary health care providers in Greece</title>
            <link>http://www.medworm.com/index.php?rid=1033767&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F14</link>
            <description>Background:
The purpose of this study was to compare technical and scale efficiency of primary care centers from the two largest Greek providers, the National Health System (NHS) and the Social Security Foundation (IKA) and to determine if, and how, efficiency is affected by various exogenous factors such as catchment population and location. 
Methods:
The sample comprised of 194 units (103 NHS and 91 IKA). Efficiency was measured with Data Envelopment Analysis (DEA) using three inputs, -medical staff, nursing/paramedical staff, administrative/other staff- and two outputs, which were the aggregated numbers of scheduled/emergency patient visits and imaging/laboratory diagnostic tests. Facilities were categorized as small, medium and large (30,000 respectively) to reflect catchment populatio...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1033767</comments>
            <pubDate>Sat, 17 Nov 2007 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1033767</guid>        </item>
        <item>
            <title>A cost function for HIV prevention services: is there a 'u' -shape?</title>
            <link>http://www.medworm.com/index.php?rid=1003960&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F13</link>
            <description>Background:
Global resource needs estimation is a critical part of addressing the HIV/AIDS epidemic. To generate these estimates knowledge of costs and cost structures is required. The evidence base for costs of HIV prevention programmes is limited. Even less is known about the existence of economies scale and whether, as economic theory suggests, average costs form a 'u'-shaped curve as scale increases. Using an econometric analysis, this paper addresses this question by estimating marginal costs and economies of scale for HIV prevention programmes for vulnerable groups in Southern India with different levels of coverage.
Methods:
Two hybrid translog-cost functions were estimated. First, expenditure data from 78 state-funded HIV prevention projects in Andhra Pradesh were used to explore t...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1003960</comments>
            <pubDate>Mon, 05 Nov 2007 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1003960</guid>        </item>
        <item>
            <title>Methods for analyzing cost effectiveness data from cluster randomized trials</title>
            <link>http://www.medworm.com/index.php?rid=846309&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F12</link>
            <description>Conclusions:
Cost effectiveness analyses alongside cluster randomized trials need to account for study design. Several theoretically coherent methods can be implemented with common statistical software. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=846309</comments>
            <pubDate>Thu, 06 Sep 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">846309</guid>        </item>
        <item>
            <title>The use of the Transition cost accounting system in health services research</title>
            <link>http://www.medworm.com/index.php?rid=787163&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F11</link>
            <description>The Transition cost accounting system integrates clinical, resource utilization, and financial information and is currently being used by several hospitals in Canada and the United States to calculate the costs of patient care. Our objectives were to review the use of hospital-based cost accounting systems to measure costs of treatment and discuss potential use of the Transition cost accounting system in health services research. Such systems provide internal reports to administrators for formulating major policies and strategic plans for future activities. Our review suggests that the Transition cost accounting information system may useful for estimating in-hospital costs of treatment. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=787163</comments>
            <pubDate>Wed, 08 Aug 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">787163</guid>        </item>
        <item>
            <title>Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: 
results of a randomised controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=760807&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F10</link>
            <description>Conclusions	If the outcome is measured by generic quality of life the nurse-led telemonitoring programme is of limited cost-effectiveness in the study population. From the societal perspective the probability of the programme being cost-effective compared to regular care was 85% at a ceiling ratio of euro 80,000 /QALY gained among the adults and 68% among the children. A decrease in the price of the asthma monitor will substantial increase the probability of the programme to be cost-effective. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=760807</comments>
            <pubDate>Fri, 27 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">760807</guid>        </item>
        <item>
            <title>The economic burden of treating neonates in Intensive Care 
Units (ICUs) in Greece</title>
            <link>http://www.medworm.com/index.php?rid=735734&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F9</link>
            <description>Conclusions:
Neonatal intensive care in Greece is associated with significant costs that exceed reimbursement from social funds. Reimbursement should be adjusted to make neonatal intensive care economically viable to private hospitals and thus, increase capacity of the services provided. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=735734</comments>
            <pubDate>Mon, 16 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">735734</guid>        </item>
        <item>
            <title>Modelling cost-effectiveness of different vasectomy methods in India, Kenya, and Mexico</title>
            <link>http://www.medworm.com/index.php?rid=731315&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F8</link>
            <description>Conclusions:
Based on the results presented, more effective methods of vasectomy--including FI, thermal cautery, and thermal cautery combined with FI--are more cost-effective than L and E alone. Analysis shows that for a programme in which a minimum of 20 clients undergo vasectomies per month, the cost per CYP is reduced in all three countries by updated vasectomy methods. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=731315</comments>
            <pubDate>Fri, 13 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">731315</guid>        </item>
        <item>
            <title>Estimating cost savings from regionalizing cardiac procedures using hospital discharge data</title>
            <link>http://www.medworm.com/index.php?rid=704793&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F7</link>
            <description>Conclusions:
Higher volumes were associated with lower costs per procedure. However, the total potential savings from regionalizing cardiac procedures is relatively minor, and may not justify the risks of reducing access to needed services. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=704793</comments>
            <pubDate>Fri, 29 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">704793</guid>        </item>
        <item>
            <title>Quantifying the economic burden of malaria in Nigeria using the willingness to pay approach</title>
            <link>http://www.medworm.com/index.php?rid=625869&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F6</link>
            <description>Conclusion:
In the long term, it is important to recognize that health and poverty are closely linked. Reducing the burden of malaria in Nigeria will help to contribute to the economic well-being of communities; and poverty-reduction will be an essential input into improving health. National malaria control programme in Nigeria and their partners need to recognize these links, and identify mechanisms for ensuring that the poorest have access to essential health interventions. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=625869</comments>
            <pubDate>Tue, 22 May 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">625869</guid>        </item>
        <item>
            <title>The economics of primary prevention of cardiovascular disease - 
A systematic review of economic evaluations</title>
            <link>http://www.medworm.com/index.php?rid=616364&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F5</link>
            <description>Conclusions:
First, this review has demonstrated the obvious lack of economic evaluations of broader health promotion interventions, when compared to clinical prevention. Second, the clear role for government to engage more actively in the economic evaluation of prevention has become very obvious, namely, to fill the gap left by private industry in terms of the evaluation of broader public health interventions and regarding clinical prevention, in light of the documented relationship between study funding and reporting of favourable results. Third, the value of greater adherence to established guidelines on economic evaluation cannot be emphasised enough. Finally, there appear to be certain methodological features in the practice of health economic evaluations that might bias the choice be...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=616364</comments>
            <pubDate>Mon, 14 May 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">616364</guid>        </item>
        <item>
            <title>Diabetes, minor depression and health care utilization and expenditures: a retrospective database study</title>
            <link>http://www.medworm.com/index.php?rid=558536&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F4</link>
            <description>Conclusions:
People with diabetes are twice as likely to have depression as the general population. Screening for and treatment of depression is warranted, as is additional research into a causal relationship between diabetes and depression. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=558536</comments>
            <pubDate>Wed, 18 Apr 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">558536</guid>        </item>
        <item>
            <title>Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country – the case of Tanzania</title>
            <link>http://www.medworm.com/index.php?rid=458203&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F3</link>
            <description>Conclusion:
Preventive cardiology is not cost-effective for any patient group in this setting until willingness to pay exceeds USD 85 per DALY. At this level of willingness to pay, the optimal intervention is Hydrochlorothiazide to patients with very high cardiovascular risk. As willingness to pay for health increase further, it becomes optimal to provide this treatment also to patients with lower cardiovascular risk, and to substitute to more sophisticated interventions. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=458203</comments>
            <pubDate>Thu, 22 Feb 2007 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">458203</guid>        </item>
        <item>
            <title>Reconciling competing priorities in commissioning: the future of bone densitometry service for North Wales</title>
            <link>http://www.medworm.com/index.php?rid=360618&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F5%2F1%2F1</link>
            <description>Conclusions:
The assessment identified significant unmet need for DXA scanning. A recommendation was made to improve access through the introduction of a new bone densitometry service based at Llandudno. This would double scanning provision provided and reduce travel costs and time for many North Wales residents. This recommendation was adopted by a joint commissioning group established by the six Local Health Boards in North Wales at the end of 2004 - evidence based commissioning in practice. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=360618</comments>
            <pubDate>Thu, 18 Jan 2007 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">360618</guid>        </item>
        <item>
            <title>The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa - a primary data analysis</title>
            <link>http://www.medworm.com/index.php?rid=309854&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F20</link>
            <description>Conclusions:
Decisions to scale-up ART across sub-Saharan Africa have been made in the absence of incremental lifetime cost and cost-effectiveness data which seriously limits attempts to secure funds at the global level for HIV treatment or to set priorities at the country level. This article presents baseline cost-effectiveness data from one of the longest running public healthcare antiretroviral treatment programmes in Africa that could assist in enhancing efficient resource allocation and equitable access to HIV treatment. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=309854</comments>
            <pubDate>Wed, 06 Dec 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">309854</guid>        </item>
        <item>
            <title>The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis</title>
            <link>http://www.medworm.com/index.php?rid=458204&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F20</link>
            <description>Conclusion:
Decisions to scale-up ART across sub-Saharan Africa have been made in the absence of incremental lifetime cost and cost-effectiveness data which seriously limits attempts to secure funds at the global level for HIV treatment or to set priorities at the country level. This article presents baseline cost-effectiveness data from one of the longest running public healthcare antiretroviral treatment programmes in Africa that could assist in enhancing efficient resource allocation and equitable access to HIV treatment. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=458204</comments>
            <pubDate>Wed, 06 Dec 2006 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">458204</guid>        </item>
        <item>
            <title>Can discrete event simulation be of use in modelling major depression?</title>
            <link>http://www.medworm.com/index.php?rid=306228&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F19</link>
            <description>Conclusion:
DES modelling appears to be an accurate, flexible and comprehensive means of depicting disease progression compared with conventional simulation methodologies. Its use in analysing recurrent and chronic diseases appears particularly useful compared with Markov processes. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=306228</comments>
            <pubDate>Tue, 05 Dec 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">306228</guid>        </item>
        <item>
            <title>Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure</title>
            <link>http://www.medworm.com/index.php?rid=222925&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F16</link>
            <description>Conclusions:
The results after 3 years follow-up of the first economic evaluation study of MARS based on empirical patient data are presented. Although high initial treatment costs for MARS occur the significantly better survival seen in this study led to reasonable costs per live year gained. Further randomized controlled trials investigating the medical efficacy and the cost-effectiveness are recommended. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=222925</comments>
            <pubDate>Thu, 05 Oct 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">222925</guid>        </item>
        <item>
            <title>Economic evaluation of a clinical protocol for diagnosing emergency patients with suspected pulmonary embolism</title>
            <link>http://www.medworm.com/index.php?rid=84051&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F12</link>
            <description>ObjectiveTo estimate the amount of cost-savings to the Australian health care system from implementing an evidence-based clinical protocol for diagnosing emergency patients with suspected pulmonary embolism (PE). 
Setting: Emergency department of a Victorian public hospital with 50,000 presentations in 2001-2002 MethodA cost-minimisation study used the data collected in a controlled clinical trial of a clinical protocol for diagnosing patients with suspected PE. The number and type of diagnostic tests in a historic cohort of 185 randomly selected patients, who presented to the emergency department with suspected PE during an eight month period prior to the clinical trial (January 2002 -August 2002) were compared with the number and type of diagnostic tests in 745 patients who presented to ...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=84051</comments>
            <pubDate>Tue, 27 Jun 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">84051</guid>        </item>
        <item>
            <title>Economic evaluation of a clinical protocol for diagnosing emergency patients with suspected pulmonary embolism.</title>
            <link>http://www.medworm.com/index.php?rid=80872&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F12</link>
            <description>ObjectiveTo estimate the amount of cost-savings to the Australian health care system from implementing an evidence-based clinical protocol for diagnosing emergency patients with suspected pulmonary embolism (PE). 
Setting: Emergency department of a Victorian public hospital with 50,000 presentations in 2001-2002 MethodA cost-minimisation study used the data collected in a controlled clinical trial of a clinical protocol for diagnosing patients with suspected PE. The number and type of diagnostic tests in a historic cohort of 185 randomly selected patients, who presented to the emergency department with suspected PE during an eight month period prior to the clinical trial (January 2002 -August 2002) were compared with the number and type of diagnostic tests in 745 patients who presented to ...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=80872</comments>
            <pubDate>Tue, 27 Jun 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">80872</guid>        </item>
        <item>
            <title>Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa</title>
            <link>http://www.medworm.com/index.php?rid=55675&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F11</link>
            <description>Conclusions There is a strong economic case for expanding PPP in TB treatment and potentially for other types of health services. Where PPPs are tailored to target groups and supported by the public sector, scaling up of effective services could occur at much lower cost than solely relying on public sector models. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=55675</comments>
            <pubDate>Tue, 06 Jun 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">55675</guid>        </item>
        <item>
            <title>Cost of illness of hyponatremia in the United States</title>
            <link>http://www.medworm.com/index.php?rid=44990&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F10</link>
            <description>Conclusion:
Treatment of hyponatremia represents a significant healthcare burden in the U.S. Newer therapies that may reduce the burden of hyponatremia in the inpatient setting could minimize the costs associated with this condition. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=44990</comments>
            <pubDate>Wed, 31 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">44990</guid>        </item>
        <item>
            <title>Enhancing the comparability of costing methods: cross-country variability in the prices of non-traded inputs to health programmes</title>
            <link>http://www.medworm.com/index.php?rid=16154&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F8</link>
            <description>Conclusion:
While the preferred option is to derive costs from a random sample of prices in each setting, this option is often not available to analysts. In this case, we suggest that the approach described in this paper could represent a better option than basing policy recommendations on results that are built on the basis of a single, or a few, price observations. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16154</comments>
            <pubDate>Mon, 24 Apr 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">16154</guid>        </item>
        <item>
            <title>Economic evaluations of non-communicable disease interventions in developing countries: a critical review of the evidence base</title>
            <link>http://www.medworm.com/index.php?rid=16155&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F7</link>
            <description>(Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16155</comments>
            <pubDate>Mon, 03 Apr 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">16155</guid>        </item>
        <item>
            <title>A population-based model for priority setting across the care continuum and across modalities</title>
            <link>http://www.medworm.com/index.php?rid=16156&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F6</link>
            <description>Conclusions:
Comparisons with other approaches to priority setting, such as Programme
Budgeting and Marginal Analysis (PBMA) and modality-based cost-effectiveness comparisons, as
typified by Australia's Pharmaceutical Benefits Advisory Committee process for the listing of
pharmaceuticals for government funding, demonstrate the value added by the HsW model notably
in its greater likelihood of contributing to allocative efficiency. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16156</comments>
            <pubDate>Tue, 28 Mar 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">16156</guid>        </item>
        <item>
            <title>Technical efficiency of district hospitals: Evidence from Namibia using Data Envelopment Analysis</title>
            <link>http://www.medworm.com/index.php?rid=16157&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F5</link>
            <description>Conclusion:
It is concluded that the existing level of pure technical and scale inefficiency of the district hospitals is considerably high and may negatively affect the government's initiatives to improve access to quality health care and scaling up of interventions that are necessary to achieve the health-related Millennium Development Goals. It is recommended that the inefficient hospitals learn from their efficient peers identified by the DEA model so as to improve the overall performance of the health system. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16157</comments>
            <pubDate>Mon, 27 Mar 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">16157</guid>        </item>
        <item>
            <title>Do coxibs reduce prescription of gastroprotective agents? Results of a record linkage study</title>
            <link>http://www.medworm.com/index.php?rid=16158&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F4</link>
            <description>Background:
Coxibs are claimed to be cost-effective drugs and reduced prescription of gastroprotective agents is assumed to be one of their major benefits. Real life prescription of these drugs may be substantially different than that considered in pharmacoeconomic analyses or claimed by drug companies, yet. Our objective was to evaluate whether coxibs were associated with reduced prescription of gastro-protective agents (GPAs, specifically proton pump inhibitors, H2 blockers and misoprostol) compared to non selective NSAIDs. 
Methods:
A record-linkage study was performed using 2001 outpatient prescription data from the province of Modena (about 632,000 inhabitants, in Northern Italy). Logistic regression was used to calculate the odds ratio of GPA prescription for coxib and non-selective ...</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16158</comments>
            <pubDate>Wed, 22 Mar 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">16158</guid>        </item>
        <item>
            <title>Developing a prioritisation framework in an English Primary Care Trust</title>
            <link>http://www.medworm.com/index.php?rid=16159&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F3</link>
            <description>Conclusion:
A technical approach to decision making is insufficient for making prioritisation decisions, however our technique provides a very valuable, structured and informed starting point for PCT decision making. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16159</comments>
            <pubDate>Fri, 17 Feb 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">16159</guid>        </item>
        <item>
            <title>Modeling the cost effectiveness of injury interventions in lower and middle income countries: opportunities and challenges</title>
            <link>http://www.medworm.com/index.php?rid=16160&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F2</link>
            <description>Conclusion:
Injury counter measures appear to be cost-effective based on models. More evaluations of real interventions will help to strengthen the evidence basis. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16160</comments>
            <pubDate>Thu, 19 Jan 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">16160</guid>        </item>
        <item>
            <title>The association between diabetes related medical costs and glycemic control: A retrospective analysis</title>
            <link>http://www.medworm.com/index.php?rid=16161&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F4%2F1%2F1</link>
            <description>Conclusion:
Almost half (44%) of all patients diagnosed with type 2 diabetes are at sub-optimal glycemic control. Evidence from this analysis indicates that the direct medical costs of treating type 2 diabetes are significantly higher for individuals who have fair or poor glycemic control than for those who have good glycemic control. Patients under fair control account for a greater proportion of the cost burden associated with antidiabetic prescription drugs. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16161</comments>
            <pubDate>Mon, 16 Jan 2006 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">16161</guid>        </item>
        <item>
            <title>The costs of reducing loss to follow-up in South African cervical cancer screening</title>
            <link>http://www.medworm.com/index.php?rid=16162&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F3%2F1%2F11</link>
            <description>Conclusion:
CHW contact with women who missed scheduled visits increased their return rate. Cost-effectiveness analyses aimed at policy decisions about cervical cancer screening in developing countries should incorporate these findings. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16162</comments>
            <pubDate>Tue, 15 Nov 2005 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">16162</guid>        </item>
        <item>
            <title>Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study</title>
            <link>http://www.medworm.com/index.php?rid=16163&amp;cid=s_31315_51_f&amp;fid=31315&amp;url=http%3A%2F%2Fwww.resource-allocation.com%2Fcontent%2F3%2F1%2F10</link>
            <description>Conclusion:
The economic evaluation results of management options for gallstone disease in Thailand differ from comparable previous studies conducted in developed countries which indicated that LC was a cost-saving strategy. Differences were due mainly to hospital costs of post operative inpatient care and value of lost working time. The LC option would be considered a cost-effective option for Thailand at a threshold of three times per capita gross domestic product recommended by the committee on the Millennium Development Goals. (Source: Cost Effectiveness and Resource Allocation)</description>
            <author>Cost Effectiveness and Resource Allocation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=16163</comments>
            <pubDate>Mon, 31 Oct 2005 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">16163</guid>        </item>
    </channel>
</rss>

